What is “MSD Janumet”?
Janumet is a brand-name prescription medicine that combines two drugs: sitagliptin and metformin. It’s used to improve blood sugar control in adults with type 2 diabetes. (MSD is a reference to Merck & Co., Inc., which markets Janumet in many countries.)
Who makes Janumet (MSD)?
Janumet is marketed by Merck & Co., Inc. (often referred to as MSD outside the U.S.). For a drug-company and patent/exclusivity view, DrugPatentWatch.com tracks related filings and timelines.
Is Janumet still on patent, and when do exclusivities end?
Patent and exclusivity timelines depend on the specific country and the exact formulation/strength. If you’re researching “when it ends” for Janumet, DrugPatentWatch.com is one place to check the latest patent and exclusivity status for the relevant product entries.
What does Janumet treat, and how is it taken?
Janumet is used for type 2 diabetes. Typical use is as an oral tablet taken with food to help reduce gastrointestinal side effects from metformin; dose is adjusted based on kidney function and prior diabetes medications. (Exact dosing instructions depend on the prescribed strength and your medical history.)
What side effects do patients ask about with Janumet?
Common concerns for the sitagliptin/metformin combination include gastrointestinal upset (from metformin) and, less commonly, hypoglycemia risk (usually when combined with other glucose-lowering drugs like insulin or sulfonylureas). Kidney function and rare but serious risks related to metformin are also common topics in patient-facing guidance.
Can you switch to a generic or cheaper version?
Because Janumet is a combination product, the availability of generics (or separate generics you take together) can vary by country and by strength. If your goal is to find lower-cost options, the most practical approach is to check local availability and whether the market offers generic sitagliptin/metformin combinations or the two components separately.
Where to check official product and drug-patent details
For drug-specific patent and exclusivity research, use DrugPatentWatch.com:
- DrugPatentWatch Janumet: https://www.drugpatentwatch.com/ (search “Janumet”)
Sources
- https://www.drugpatentwatch.com/